Permeation enhancer strategies in transdermal drug delivery

Drug Delivery

Volumn 23, Issue 2, 2016, Pages 564-578

  Marwah, Harneet ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Iontophoresis; nano carriers; permeation enhancement; sonophoresis; transdermal drug delivery

Indexed keywords

NANOCARRIER; PENETRATION ENHANCING AGENT; DELAYED RELEASE FORMULATION; DRUG; DRUG CARRIER; EXCIPIENT;

CIRCULATION; DERMIS; DIFFUSION COEFFICIENT; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TRANSPORT; ELECTROPORATION; FIRST PASS EFFECT; HUMAN; HUMAN TISSUE; HYDRATION; IONIZATION; IONTOPHORESIS; MACROMOLECULE; MELTING POINT; MOLECULAR SIZE; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SKIN TEMPERATURE; STRATUM CORNEUM; SUBCUTANEOUS TISSUE; TRANSDERMAL DRUG DELIVERY SYSTEM; ULTRASOUND; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DELAYED RELEASE FORMULATION; DEVICES; DRUG DELIVERY SYSTEM; DRUG FORMULATION; METABOLISM; PERMEABILITY; PHARMACEUTICS; PHARMACOKINETICS; PROCEDURES; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SKIN; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 84954349709     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.935532     Document Type: Review

References (89)

1. Arora N, Singh K, Garg T. (2012). Areas of nanomedicine applications. Int J Univ Pharm Life Sci 2: 216-27
2. Barker DJ, Bercovicz D, Servilio LC, et al. (2013). Rat ultrasonic vocalizations demonstrate that the motivation to contextually reinstate cocaine-seeking behavior does not necessarily involve a hedonic response. Addict Biol. [Epub ahead of print]. doi: 10.1111/adb.12044
3. Basnet P, Hussain H, Tho I, Skalko-Basnet N. (2012). Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci 101: 598-609
4. Bei D, Meng J, Youan BB. (2010). Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine (Lond) 5: 1385-99
5. Brown L, Langer R. (1988). Transdermal delivery of drugs. Annu Rev Med 39: 221-9
6. Cao J, Guo LH, Wan B, Wei Y. (2011). In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A. J Environ Sci (China) 23: 315-21
7. Chen M, Gupta V, Anselmo AC, et al. (2014). Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers. J Control Release 173: 67-74
8. Csizmazia E, Berko S, Maroda M, et al. (2012). [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect]. Acta Pharm Hung 82: 15-22
9. Degano P, Schneider J, Hannan CM, et al. (1999). Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 18: 623-32
10. Desai PR, Marepally S, Patel AR, et al. (2013). Topical delivery of anti-TNFalpha siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. J Control Release 170: 51-63
11. Dhote V, Bhatnagar P, Mishra PK, et al. (2012). Iontophoresis: a potential emergence of a transdermal drug delivery system. Sci Pharm 80: 1-28
12. Donnelly RF, Morrow DI, McCrudden MT, et al. (2014). Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors. Photochem Photobiol 90: 641-7
13. Duan D, Moeckly C, Gysbers J, et al. (2011). Enhanced delivery of topically-applied formulations following skin pre-treatment with a hand-applied, plastic microneedle array. Curr Drug Deliv 8: 557-65
14. Dubey V, Mishra D, Jain NK. (2007). Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 67: 398-405
15. Dudelzak J, Hussain M, Phelps RG, et al. (2008). Evaluation of histologic and electron microscopic changes after novel treatment using combined microdermabrasion and ultrasound-induced phonophoresis of human skin. J Cosmet Laser Ther 10: 187-92
16. Durand C, Alhammad A, Willett KC. (2012). Practical considerations for optimal transdermal drug delivery. Am J Health Syst Pharm 69: 116-24
17. El-Kamel AH, Al-Fagih IM, Alsarra IA. (2008). Effect of sonophoresis and chemical enhancers on testosterone transdermal delivery from solid lipid microparticles: an in vitro study. Curr Drug Deliv 5: 20-6
18. Elmoslemany RM, Abdallah OY, El-Khordagui LK, Khalafallah NM. (2012). Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech 13: 723-31
19. Erdal MS, Pekoz AY, Aksu B, Araman A. (2014). Impacts of chemical enhancers on skin permeation and deposition of terbinafine. Pharm Dev Technol 19: 565-70
20. Eriksson F, Totterman T, Maltais AK, et al. (2013). DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer. Vaccine 31: 3843-8
21. Fang JY, Hong CT, Chiu WT, Wang YY. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219: 61-72
22. Fiala S, Jones SA, Brown MB. (2010). A fundamental investigation into the effects of eutectic formation on transmembrane transport. Int J Pharm 393: 68-73
23. Foldvari M, Badea I, Kumar P, et al. (2011). Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections. Curr Drug Deliv 8: 307-19
24. Fowler JF, Warshaw EM, Squires L. (2009). Methylphenidate patch-test protocol and irritancy threshold determination in healthy adult subjects. Dermatitis 20: 271-4
25. Fukushima K, Ise A, Morita H, et al. (2011). Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 28: 7-21
26. Gagandeep G, Garg T, Malik B, et al. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53: 10-16
27. Garg T. (2012). An evolutionary approaches in development of needle free injection technologies. Int J Pharm Pharm Sci 4: 590-6
28. Garg T. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 1-8. [Epub ahead of print]
29. Garg T, Bilandi A, Kapoor B. (2011a). Organogels: advanced and novel drug delivery system. Int Res J Pharm 2: 15-21
30. Garg T, Singh O, Arora S. (2011b). Opportunities and growth of conduct clinical trials in India. Int J Pharm Sci Rev Res 8: 152-60
31. Garg T, Singh O, Arora S, Murthy R. (2011c). Dendrimer-a novel scaffold for drug delivery. Int J Pharm Sci Rev Res 7: 211-20
32. Garg T, Singh O, Arora S, Murthy R. (2011d). Patented microencapsulation techniques and its application. J Pharm Res 4: 2097-102
33. Garg T, Bilandi A, Kapoor B. (2012a). Evolutionary approaches for drug and gene delivery by micro and nano magnetic carriers. Indo Global Res J Pharm Sci 2: 182-9
34. Garg T, Chanana A, Sharma G. (2012b). Pulsatile drug delivery systems: pulsincap system. IOSR J Pharm 2: 338-9
35. Garg T, Goyal AK, Arora S, Murthy R. (2012c). Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2: 251-61
36. Garg T, Singh O, Arora S, Murthy R. (2012d). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29: 1-63
37. Garg T, Goyal AK. (2012). Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2: 270-80
38. Garg T, Goyal AK. (2014a). Biomaterial-based scaffolds-current status and future directions. Expert Opin Drug Deliv 11: 767-89
39. Garg T, Goyal AK. (2014b). Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4: 62-71
40. Garg T, Goyal AK. (2014c). Medicated chewing gum: patient compliance oral drug delivery system. Drug Deliv Lett 4: 72-8
41. Garg T, Rath G, Goyal AK. (2014). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv. [Epub ahead of print]
42. Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30: 369-409
43. Ghaffarian R, Muro S. (2013). Models and methods to evaluate transport of drug delivery systems across cellular barriers. J Vis Exp (80):e50638
44. Gomez I, Szabo A, Pap L Jr, et al. (2012). In vivo calcium and phosphate iontophoresis for the topical treatment of osteoporosis. Phys Ther 92: 289-97
45. Goyal AK, Rath G, Garg T. (2013a). Nanotechnological approaches for genetic immunization. DNA RNA Nanobiotechnol Med Diagn Treat Dis 67-120
46. Goyal G, Garg T, Malik B, et al. (2013b). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2013.855277
47. Haftek M, Teillon MH, Schmitt D. (1998). Stratum corneum, corneodesmosomes and ex vivo percutaneous penetration. Microsc Res Tech 43: 242-9
48. Ham AS, Cost MR, Sassi AB, et al. (2009). Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Pharm Res 26: 502-11
49. Han G, Tar M, Kuppam DS, et al. (2010). Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med 7: 224-33
50. Hashim II, Motoyama K, Abd-Elgawad AE, et al. (2010). Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides. Int J Pharm 393: 127-34
51. Hou J, Zuo G, Shen G, et al. (2009). Hollow sodium tungsten bronze (Na0.15WO3) nanospheres: preparation, characterization, and their adsorption properties. Nanoscale Res Lett 4: 1241-6
52. Jain S, Tiwary AK, Sapra B, Jain NK. (2007). Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8: E111
53. Jones DS, Moss GP. (2010). Themed issue: recent advances in transdermal drug delivery. J Pharm Pharmacol 62: 669-70
54. Kataria K, Sharma A, Garg T, et al. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4: 79-86
55. Kaur M, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31: 49-88
56. Kaur M, Malik B, Garg T, et al. (2014b). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.894594
57. Kaur R, Garg T, Malik B, et al. (2014c). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv 1-6
58. Kim J, Jang JH, Lee JH, et al. (2012). Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation. Pharm Res 29: 2017-29
59. Kim ST, Lee KM, Park HJ, et al. (2009). Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis. J Gene Med 11: 26-37
60. Lee S, Kollias N, McAuliffe DJ, et al. (1999). Topical drug delivery in humans with a single photomechanical wave. Pharm Res 16: 1717-21
61. Li N, Peng LH, Chen X, et al. (2014). Antigen-loaded nanocarriers enhance the migration of stimulated Langerhans cells to draining lymph nodes and induce effective transcutaneous immunization. Nanomedicine 10: 215-23
62. Liu H, Wang Y, Han F, et al. (2007). Gelatin-stabilised microemulsion-based organogels facilitates percutaneous penetration of Cyclosporin A in vitro and dermal pharmacokinetics in vivo. J Pharm Sci 96: 3000-9
63. Luis J, Park EJ, Meyer RJ, Smith NB. (2007). Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery. J Acoust Soc Am 122: 2022-30
64. Mackay IR, Rosen FS, Kay A. (2001). Allergy and allergic diseases. N Engl J Med 344: 30-7
65. Mahor S, Rawat A, Dubey PK, et al. (2007). Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm 340: 13-19
66. Manosroi A, Khanrin P, Lohcharoenkal W, et al. (2010). Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392: 304-10
67. Mohammadi-Samani S, Yousefi G, Mohammadi F, Ahmadi F. (2014). Meloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation. Iran J Basic Med Sci 17: 112-18
68. Montanari J, Vera M, Mensi E, et al. (2013). Nanoberries for topical delivery of antioxidants. J Cosmet Sci 64: 469-81
69. Murphy M, Carmichael AJ. (2000). Transdermal drug delivery systems and skin sensitivity reactions. Am J Clin Dermatol 1: 361-8
70. Nam SH, Xu YJ, Nam H, et al. (2011). Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. Int J Pharm 419: 114-20
71. Onishi H, Machida Y, Koyama K. (2007). Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles. Drug Dev Ind Pharm 33: 641-7
72. Park CW, Son DD, Kim JY, et al. (2012). Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system. Int J Pharm 436: 32-40
73. Parnami N, Garg T, Rath G, Goyal AK. (2013). Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2013.837474
74. Patel RP, Baria AH. (2011). Formulation and evaluation considerations of transdermal drug delivery system. Int J Pharm Res 3: 1-9
75. Rehman K, Zulfakar MH. (2014). Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm 40: 433-40
76. Romero EL, Morilla MJ. (2013). Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. Int J Nanomed 8: 3171-86
77. Schoellhammer CM, Blankschtein D, Langer R. (2014). Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expert Opin Drug Deliv 11: 393-407
78. Sharma N, Agarwal G, Rana A, et al. (2011). A review: transdermal drug delivery system: a tool for novel drug delivery system. Int J Drug Dev Res 3: 70-84
79. Singh D, Pradhan M, Nag M, Singh MR. (2014a). Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.883401
80. Singh H, Sharma R, Joshi M, et al. (2014b). Transmucosal delivery of docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.885442
81. Singh O, Garg T, Rath G, Goyal AK. (2014c). Microbicides for the treatment of sexually transmitted hiv infections. J Pharm 1-18
82. Singh K, Arora N, Garg T. (2012a). RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res 2: 113-27
83. Singh K, Arora N, Garg T. (2012b). Superbug: antimicrobial resistance due to NDM-1. Int J Inst Pharm Life Sci 2: 58-66
84. Skountzou I, Kang SM. (2009). Transcutaneous immunization with influenza vaccines. Curr Top Microbiol Immunol 333: 347-68
85. Subedi RK, Oh SY, Chun MK, Choi HK. (2010). Recent advances in transdermal drug delivery. Arch Pharm Res 33: 339-51
86. Sun R, Celli A, Crumrine D, et al. (2014). Functional epidermal permeability barrier in human epidermal equivalents. Tissue Eng Part C Methods. [Epub ahead of print]
87. Tiwari SB, Pai RM, Udupa N. (2004). Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin. Drug Deliv 11: 47-51
88. Valenta C, Siman U, Kratzel M, Hadgraft J. (2000). The dermal delivery of lignocaine: influence of ion pairing. Int J Pharm 197: 77-85
89. Vinod K, Sarvani P, Banji D, Teja B. (2010). Transdermal drug delivery system-over coming challenges of popular drug delivery system. Int J Pharm World Res 3: 49-53